Jinbo Yue
Clinical trials sponsored by Jinbo Yue, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Triple therapy shrinks bile duct tumors, may enable surgery Results expected Jul 2027 (estimated)
-
Triple therapy shrinks bile duct tumors, may enable surgery
Disease control Recruiting nowThis phase II trial tests a combination of immunotherapy (tislelizumab), chemotherapy (gemcitabine plus cisplatin or oxaliplatin), and targeted radiation before possible surgery in 38 people with hilar cholangiocarcinoma that is borderline or not removable. The goal is to see if …
Phase 2 • Sponsor: Jinbo Yue • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New combo therapy targets stomach cancer lymph nodes
Disease control Recruiting nowThis phase II trial tests whether adding surgery and radiation to standard chemotherapy can improve outcomes for people with stomach cancer that has spread only to nearby lymph nodes. About 54 participants will receive either standard chemo or a more intensive plan including chem…
Phase 2 • Sponsor: Jinbo Yue • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC